🇺🇸 FDA
Company

Rein

Rein Therapeutics

RNTX pharma USA

Quick answer

Rein is a pharma company (RNTX) headquartered in AUSTIN, TX, USA with 5 tracked pipeline programs.

Pipeline (5)

project

Nivolumab

Metastatic Kidney Cancer

Phase 3 · small_molecule · active

1 trials project

LTI-01

Pleural Effusion

Phase 2 · small_molecule · completed

1 trials project

LTI-03

Idiopathic Pulmonary Fibrosis (IPF)

Phase 2 · small_molecule · active

1 trials project

Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03)

Idiopathic Pulmonary Fibrosis

Phase 1 · small_molecule · completed

1 trials project

LTI-03

Idiopathic Pulmonary Fibrosis

Phase 1 · small_molecule · completed

1 trials

Patents (8)

patent

US 12390512

Depolymerase capable of degrading extracellular polymeric substances of Klebsiel

Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11033623

Magnetic stem cell therapy for lesions

Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10472381

Sialic acid derivatives

Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10265396

Magnetic extracellular matrix

Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9539228

Composition containing lysine as a nutritional supplement or treatment in the ca

Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8309071

Foamy viral envelope genes

Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8293803

Retinoid compounds and their use

Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8268792

Use of an active ingredient combination that contains hydroxystilbene for preven

Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)